BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14736941)

  • 1. A 38-year history of natural-killer-cell lymphoma.
    Schrader C; Janssen D; Kneba M; Lennert K
    N Engl J Med; 2004 Jan; 350(4):418-9. PubMed ID: 14736941
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal NK/T-cell lymphoma causing diagnostic difficulties.
    Nigidie A; Schneider J
    Ethiop Med J; 2005 Jul; 43(3):197-201. PubMed ID: 16370552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances of nasal natural killer/T-cell lymphoma].
    Liu Y; Yang HY; Lu MZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):809-12. PubMed ID: 16545194
    [No Abstract]   [Full Text] [Related]  

  • 4. Lethal midline granuloma-nasal natural killer/T-cell lymphoma.
    Mendenhall WM; Olivier KR; Lynch JW; Mendenhall NP
    Am J Clin Oncol; 2006 Apr; 29(2):202-6. PubMed ID: 16601443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal midline granuloma revisited: nasal T/Natural-killer cell lymphoma.
    Chim CS; Ooi GC; Shek TW; Liang R; Kwong YL
    J Clin Oncol; 1999 Apr; 17(4):1322-5. PubMed ID: 10561195
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral and maxillofacial pathology case of the month. Angiocentric T-Cell lymphoma (midline lethal granuloma).
    Johnson CD; Busaidy KF; Bouquot JE
    Tex Dent J; 2007 Aug; 124(8):764-5, 772-3. PubMed ID: 17867546
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nasal NK/T lymphoma. A case report].
    Ladeb S; Gaulard P; Ben Othmen T; Abd Alsamad I; Delfau-Larue MH; Abdelkefi A; Torjmen L; Ben Abdeladhim A
    Ann Pathol; 2003 Apr; 23(2):149-52. PubMed ID: 12843969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive sinonasal natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis.
    Turner JH; Loyo M; Lin SY
    Am J Otolaryngol; 2012; 33(1):188-91. PubMed ID: 21764176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
    Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extranodal NK/T-cell lymphoma, nasal type].
    Sato Y; Yoshino T
    Rinsho Ketsueki; 2007 May; 48(5):353-4. PubMed ID: 17571578
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of extranodal natural killer/T-cell lymphoma, nasal type, to interferon-alpha, corticosteroid and narrowband ultraviolet B phototherapy.
    Tai WC; Li HP; Lin TY; Lin CY; Wu MT
    Clin Exp Dermatol; 2009 Dec; 34(8):e927-30. PubMed ID: 20055869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy alone for nasal natural-killer/T-cell lymphoma.
    Bahl G; Laskar S; Muckaden MA
    J Clin Oncol; 2006 Jun; 24(17):2684-5; author reply 2685-6. PubMed ID: 16763286
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
    Widmer S; Tinguely M; Egli F; Thiel MA
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal T/NK cell lymphoma: report of 3 cases involving the palate.
    Tsang WM; Tong AC; Lam KY; Tideman H
    J Oral Maxillofac Surg; 2000 Nov; 58(11):1323-7. PubMed ID: 11078150
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment for NK-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2004 Mar; 45(3):209-17. PubMed ID: 15103934
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal NK/T cell lymphoma presenting as a lethal midline granuloma.
    Mehta V; Balachandran C; Bhat S; Geetha V; Fernandes D
    Indian J Dermatol Venereol Leprol; 2008; 74(2):145-7. PubMed ID: 18388376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
    Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
    Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.